Jordan Jacob S, Harper Conner C, Williams Evan R
Department of Chemistry, University of California, Berkeley, California 94720-1460, United States.
Anal Chem. 2024 Dec 3;96(48):19126-19133. doi: 10.1021/acs.analchem.4c04669. Epub 2024 Oct 12.
Protein aggregation is involved in many human diseases, but characterizing the sizes and shapes of intermediate oligomers (∼10-100 nm) that are important to the formation of macroscale aggregates like amyloid fibrils is a significant analytical challenge. Here, charge detection mass spectrometry (CDMS) is used to characterize individual conformational states of bovine serum albumin oligomers with up to ∼225 molecules (15 MDa). Elongated, partially folded, and globular conformational families for each oligomer can be readily distinguished based on the extent of charging. The abundances of individual conformers vary with changes in the monomer concentration or by adding aggregation inhibitors, such as SDS, heparin, or MgCl. These results show the potential of CDMS for investigating intermediate oligomers in protein aggregation processes that are important for understanding aggregate formation and inhibition mechanisms and could accelerate formulation buffer development to prevent the aggregation of biotherapeutics.
蛋白质聚集与许多人类疾病有关,但表征对淀粉样纤维等宏观聚集体形成至关重要的中间寡聚体(约10 - 100纳米)的大小和形状是一项重大的分析挑战。在此,电荷检测质谱(CDMS)用于表征多达约225个分子(15兆道尔顿)的牛血清白蛋白寡聚体的各个构象状态。基于带电程度,可以很容易地区分每个寡聚体的伸长、部分折叠和球状构象家族。单个构象体的丰度会随着单体浓度的变化或通过添加聚集抑制剂(如SDS、肝素或MgCl)而改变。这些结果表明CDMS在研究蛋白质聚集过程中的中间寡聚体方面具有潜力,这对于理解聚集体形成和抑制机制很重要,并且可以加速用于防止生物治疗药物聚集的制剂缓冲液的开发。